AK119
AK119 Uses, Dosage, Side Effects, Food Interaction and all others data.
AK119 is a humanized anti-CD73 monoclonal antibody being investigated in the clinical trial NCT04516564 (A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects).
Trade Name | AK119 |
Generic | AK119 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
How AK119 works
AK119 binds to, and inhibits, human CD73 with high affinity. It was seen to result in CD73 internalization and promotion of IgG production from B cells in studies. This drug is currently being investigated as immunotherapy for COVID-19.
Innovators Monograph
You find simplified version here AK119